Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex.
about
RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effectsKRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasisMutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progressionDifferential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon.Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancerDegradation of activated K-Ras orthologue via K-Ras-specific lysine residues is required for cytokinesis.Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer.Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras.Gelsolin: the tail of a molecular gymnast.The role of wild type RAS isoforms in cancer.RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA.Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras.KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.
P2860
Q34081008-33A31229-558A-47BA-9C86-473859D34F5BQ34509268-416FB699-B56D-425C-8646-1447CB24C422Q34934116-78C766F6-8D7B-4778-BA66-2F035AB3E787Q36678062-EE950E88-CF07-431A-87B3-21C7DD7BC882Q36697241-D02715C7-005E-4631-ABDE-EB4D54645E8BQ36942851-5CC394F8-2E3B-4305-BDC8-0736BE3B5715Q37132173-49CA1542-DE03-4240-8E9E-DA696E243BBEQ37583441-A00BF0CF-A5B5-44C7-B6D4-AF5B16E2F1A1Q37610817-2577A474-68A1-4D89-BDD0-5B7243A9A4C9Q37899488-C3911E4B-A611-4573-9E19-3F9751C30338Q38113172-702FCA8A-0ADA-4580-8232-E40967DBE8D1Q38898397-A9B4C1B3-6EED-46C0-B1E6-9C8F8D7329BBQ39321821-4E5F1D6C-3754-49BE-978F-12A724502391Q39474160-1E8799F9-5D80-4F8D-A65A-4A73291A2F1EQ41970788-52DBEB30-1589-4801-A4D8-C7551706308CQ42122955-08E58752-94B4-48D3-ABCF-86D48D205A8FQ47248242-85CFB2AB-FBC9-447C-850B-23783C5F3799
P2860
Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Oncogenic K-RAS subverts the a ...... of the N-RAS:gelsolin complex.
@en
type
label
Oncogenic K-RAS subverts the a ...... of the N-RAS:gelsolin complex.
@en
prefLabel
Oncogenic K-RAS subverts the a ...... of the N-RAS:gelsolin complex.
@en
P2093
P2860
P356
P1433
P1476
Oncogenic K-RAS subverts the a ...... of the N-RAS:gelsolin complex.
@en
P2093
J L Franklin
J W Keller
K M Haigis
R H Whitehead
R J Coffey
P2860
P2888
P304
P356
10.1038/SJ.ONC.1210103
P407
P577
2006-11-20T00:00:00Z
P5875
P6179
1008809397